Home / Posts Tagged "USFDA"

Aparna Pharmaceuticals Private Limited, a leader in manufacturing Active Pharmaceutical Ingredients (APIs) and Advanced Drug Intermediates, is pleased to announce that its manufacturing facility, Aparna Organics Limited, located in Pydibhimavaram, Srikakulalam, Andhra Pradesh, India has received VAI classification from the United States Food and Drug

READ MORE

In its steadfast commitment to enhancing quality healthcare access, Mankind Pharma, a leading pharmaceutical company is proud to unveil a significant stride with the introduction of 120 DMF (Drug Master File) Quality Medicines in the Indian market. Committed to delivering exceptional healthcare solutions at affordable

READ MORE

CEPI to provide funding of up to US$3.6 million to advance the development of Gennova Biopharmaceutical’s self-amplifying thermostable mRNA vaccine platform to develop vaccine candidates against Disease X. • Funding will support optimisation of the technology platform to enhance immunogenicity. 8 August 2023, OSLO Norway: The Coalition for Epidemic

READ MORE

The US Food and Drug Administration (FDA) has granted Axiostat Gauze, a line of advanced hemostatic gauze that stops severe traumatic bleeding, 510(k) clearance, according to Axio Biosolutions, a pioneer in cutting-edge advanced woundcare products. Z-fold axiostat Hemostatic gauze, which is used by many military services

READ MORE

Concept Medical, a globally recognised leader in innovative medical devices, has achieved a remarkable milestone by becoming the first medical company to receive its fourth Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration (USFDA) to treat Superficial Femoral Arteries (SFA). The

READ MORE

Arunachal Pradesh currently has 4,266 active cases, while 41,385 people have recovered from the disease thus far, including 360 in the last 24 hours. Zydus Cadila gets USFDA nod for arthritis drug Drug firm Zydus Cadila on Monday said it has received final approval from the US

READ MORE

Aurabeat, USFDA approved anti-Covid Class 2 medical device for SARS-COV-2 disinfection was launched in India today.  Hong Kong-based Aurabeat has developed the patented AG+ five-stage sterilization purifying technology after extensive research in the field of air filtration for over a decade, Aurabeat’s AG+ Pro Silver

READ MORE